[Cytostatic platinum complexes: an unexpected discovery with considerable consequences]
- PMID: 3736675
- DOI: 10.1007/BF00367775
[Cytostatic platinum complexes: an unexpected discovery with considerable consequences]
Abstract
Antineoplastic platinum complexes represent new-developed inorganic cytostatics, which interfere with intracellular nucleic acids, especially with DNA. The main representative is cis-diamminedichloroplatinum (II) (cis-platin, DDP). It has proven effective against human urogenital tumors and against carcinomas of the head and neck. The most severe side effects are nephrotoxicity and gastrointestinal irritation. Stimulated by the clinical success of cisplatin, a series of platinum complexes of the second generation has been recently developed. Moreover, anti-tumor properties were detected for various organometallic complexes containing titanium, vanadium, tin, or iron as central atoms.
Similar articles
-
Non platinum metal complexes as anti-cancer drugs.Arch Pharm (Weinheim). 2007 Mar;340(3):117-26. doi: 10.1002/ardp.200600151. Arch Pharm (Weinheim). 2007. PMID: 17315259 Review.
-
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.Br J Cancer. 1999 Aug;80(12):1912-9. doi: 10.1038/sj.bjc.6690620. Br J Cancer. 1999. PMID: 10471039 Free PMC article.
-
Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.Cancer Res. 1983 Oct;43(10):4927-34. Cancer Res. 1983. PMID: 6683993
-
Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).Cancer Chemother Pharmacol. 1995;35(5):371-6. doi: 10.1007/s002800050249. Cancer Chemother Pharmacol. 1995. PMID: 7850917
-
Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment.Curr Med Chem Anticancer Agents. 2005 Mar;5(2):137-47. doi: 10.2174/1568011053174873. Curr Med Chem Anticancer Agents. 2005. PMID: 15777221 Review.
Cited by
-
Platinum antitumour agents: a review of (bio)analysis.Pharm Weekbl Sci. 1992 Jun 19;14(3):61-77. doi: 10.1007/BF01962689. Pharm Weekbl Sci. 1992. PMID: 1630874 Review.
-
Formation and stability of interstrand cross-links induced by cis- and trans-diamminedichloroplatinum (II) in the DNA of Saccharomyces cerevisiae strains differing in repair capacity.Curr Genet. 1989 Dec;16(5-6):331-8. doi: 10.1007/BF00340711. Curr Genet. 1989. PMID: 2692851
-
[Cytostatic non-platinum metal complexes: new perspectives for the treatment of cancer?].Naturwissenschaften. 1987 Aug;74(8):374-82. doi: 10.1007/BF00405465. Naturwissenschaften. 1987. PMID: 3309682 Review. German.
-
The antitumor activity of the platinum complex D-17872 is associated with tumor cell differentiation.Cancer Chemother Pharmacol. 1993;32(2):123-8. doi: 10.1007/BF00685614. Cancer Chemother Pharmacol. 1993. PMID: 8485806
-
Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas.Cancer Chemother Pharmacol. 1991;27(6):464-71. doi: 10.1007/BF00685161. Cancer Chemother Pharmacol. 1991. PMID: 2013116